William New

William New

GSK Reports On Corporate Responsibility

United Kingdom pharmaceutical company GlaxoSmithKline on Tuesday reported on its corporate responsibility activities in 2008 and 2009, including a commitment to cutting prices on patented medicines for poor countries. GSK’s recent public announcement on access to medicines has generated some…

WIPO, UNCITRAL Team Up On IP And Finance

Officials from two lawyerly United Nations agencies met recently to discuss their roles and build cooperation in intellectual property finance, especially in light of the global economic crisis.

US Senate Approves Kirk As USTR

The United States Senate on Wednesday overwhelmingly approved the nomination of United States Trade Representative (USTR) designee Ron Kirk as the nation’s 16th trade representative, according to a USTR office release. As USTR, Kirk is member of President Obama’s Cabinet…

World Health Organization Issues Statement On Generic Drug Seizures

The World Health Organization on Friday issued a statement on a high-profile debate over Dutch customs authorities’ delays of shipments of legitimate generic pharmaceuticals passing through the European country on their way to patients in developing countries. The goods were apparently believed to be counterfeit medicines.

WIPO Faces Possible Negative Annual Income Despite Record Trademark Filings

The World Intellectual Property Organization is facing the possibility of negative income for the first time in its history, the United Nations agency’s director general said Monday. Director General Francis Gurry made the remarks during a press conference on its annual report on trademark filings at WIPO in 2008 that showed a new record high for trademark registrations but signs of a slowdown late in the year.

Administrative Patent Validity Determinations If The Proposed US Patent Reform Act Of 2009 Passes

On 3 March, 2009, bills were introduced in the US Congress setting forth the proposed "Patent Reform Act of 2009". The legislation proposes significant changes to post-issuance proceedings available to challenge patents in the United States. US attorneys Matthew A. Smith, Stephen B. Maebius and Jon W. Dudas argue the proposed legislation will be a step toward improving patent quality.

Alarm Escalates Over Delayed Generic Drug Shipments As Action Sought

Health advocates on Friday escalated their alarm over recent seizures by the Dutch government of shipments of legitimate generic pharmaceuticals passing through Europe on their way to developing countries. The European Commission has defended its actions as permissible under its own and international rules, but is being asked to look more carefully at those rules.

WHO Launches Online Hearing On Innovative Funding Sources For R&D

The World Health Organization is soliciting new ideas for funding sources to stimulate research and development on diseases predominantly afflicting developing countries, with some in developed countries. The web-based public hearing, being held online from 7 March to 15 April, will contribute to an intergovernmental mandate to come up with ways to address the shortage of research in this areas.

Concerns Continue Over Generic Drug Seizures As Legality Debates Begin

Developing nations led by Brazil and India, along with public health providers and advocates, this week continue to press strong concern over seizures of legitimate shipments of generic pharmaceuticals destined for poor patients in the developing world. Raising the issue at the World Trade Organization again, they say new research into numerous shipments of legitimate drugs delayed by authorities in the Netherlands have elevated doubts and may mean potentially thousands of patients put at risk.